ATE139120T1 - Verwendung von rapamycin zur behandlung des diabetes - Google Patents

Verwendung von rapamycin zur behandlung des diabetes

Info

Publication number
ATE139120T1
ATE139120T1 AT92302842T AT92302842T ATE139120T1 AT E139120 T1 ATE139120 T1 AT E139120T1 AT 92302842 T AT92302842 T AT 92302842T AT 92302842 T AT92302842 T AT 92302842T AT E139120 T1 ATE139120 T1 AT E139120T1
Authority
AT
Austria
Prior art keywords
rapamycin
treat diabetes
insulin
arresting
retarding
Prior art date
Application number
AT92302842T
Other languages
English (en)
Inventor
William Lee Baeder
Surendra Nath Sehgal
Laurel Moore Adams
Thomas Joseph Caggiano
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/792,105 external-priority patent/US5321009A/en
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE139120T1 publication Critical patent/ATE139120T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
AT92302842T 1991-04-03 1992-03-31 Verwendung von rapamycin zur behandlung des diabetes ATE139120T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67970691A 1991-04-03 1991-04-03
US07/792,105 US5321009A (en) 1991-04-03 1991-11-14 Method of treating diabetes

Publications (1)

Publication Number Publication Date
ATE139120T1 true ATE139120T1 (de) 1996-06-15

Family

ID=27102296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92302842T ATE139120T1 (de) 1991-04-03 1992-03-31 Verwendung von rapamycin zur behandlung des diabetes

Country Status (19)

Country Link
EP (1) EP0507555B1 (de)
JP (1) JP2535119B2 (de)
AT (1) ATE139120T1 (de)
AU (1) AU652037B2 (de)
CA (1) CA2064678A1 (de)
CZ (1) CZ282733B6 (de)
DE (1) DE69211406T2 (de)
DK (1) DK0507555T3 (de)
ES (1) ES2089395T3 (de)
GR (1) GR3020316T3 (de)
HK (1) HK108797A (de)
HU (1) HUT60626A (de)
IE (1) IE74884B1 (de)
IL (1) IL101353A0 (de)
MX (1) MX9201513A (de)
NO (1) NO921279L (de)
NZ (1) NZ242190A (de)
SG (1) SG43075A1 (de)
SK (1) SK279180B6 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378696A (en) * 1990-09-19 1995-01-03 American Home Products Corporation Rapamycin esters
US5177203A (en) * 1992-03-05 1993-01-05 American Home Products Corporation Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5256790A (en) * 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
CA2106034A1 (en) * 1992-09-24 1994-03-25 Ralph J. Russo 21-norrapamycin
US5480989A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5480988A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5302584A (en) * 1992-10-13 1994-04-12 American Home Products Corporation Carbamates of rapamycin
US5434260A (en) * 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
US5489680A (en) * 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
US5349060A (en) * 1993-01-07 1994-09-20 American Home Products Corporation Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
US5252579A (en) * 1993-02-16 1993-10-12 American Home Products Corporation Macrocyclic immunomodulators
US7279561B1 (en) 1993-04-23 2007-10-09 Wyeth Anti-rapamycin monoclonal antibodies
US5504091A (en) * 1993-04-23 1996-04-02 American Home Products Corporation Biotin esters of rapamycin
AU686629B2 (en) 1993-04-23 1998-02-12 Wyeth Rapamycin Conjugates and Antibodies
US5387680A (en) * 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
US5391730A (en) * 1993-10-08 1995-02-21 American Home Products Corporation Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5373014A (en) * 1993-10-08 1994-12-13 American Home Products Corporation Rapamycin oximes
US5378836A (en) * 1993-10-08 1995-01-03 American Home Products Corporation Rapamycin oximes and hydrazones
US5385910A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Gem-distributed esters of rapamycin
US5385908A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
US5385909A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Heterocyclic esters of rapamycin
US5389639A (en) * 1993-12-29 1995-02-14 American Home Products Company Amino alkanoic esters of rapamycin
US5525610A (en) * 1994-03-31 1996-06-11 American Home Products Corporation 42-Epi-rapamycin and pharmaceutical compositions thereof
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5496831A (en) * 1994-05-13 1996-03-05 The General Hospital Corporation Inhibition of insulin-induced adiposis
US5463048A (en) * 1994-06-14 1995-10-31 American Home Products Corporation Rapamycin amidino carbamates
US5491231A (en) * 1994-11-28 1996-02-13 American Home Products Corporation Hindered N-oxide esters of rapamycin
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
US5561138A (en) * 1994-12-13 1996-10-01 American Home Products Corporation Method of treating anemia
US5496832A (en) * 1995-03-09 1996-03-05 American Home Products Corporation Method of treating cardiac inflammatory disease
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
TW427904B (en) * 1995-12-07 2001-04-01 American Home Prod Neuroprotective agents
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
US5922730A (en) * 1996-09-09 1999-07-13 American Home Products Corporation Alkylated rapamycin derivatives
US6015809A (en) * 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
WO2002022805A2 (en) * 2000-09-14 2002-03-21 Beth Israel Deaconess Medical Center, Inc. Modulation of il-2- and il-15-mediated t cell responses
US20040023885A1 (en) 2002-06-07 2004-02-05 Brand Stephen J Compositions and methods for treating diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5023263A (en) * 1990-08-09 1991-06-11 American Home Products Corporation 42-oxorapamycin

Also Published As

Publication number Publication date
DE69211406T2 (de) 1996-11-28
SK97292A3 (en) 1994-11-09
JPH0597688A (ja) 1993-04-20
AU1395792A (en) 1992-10-08
SK279180B6 (sk) 1998-07-08
AU652037B2 (en) 1994-08-11
HK108797A (en) 1997-08-22
HUT60626A (en) 1992-10-28
CZ282733B6 (cs) 1997-09-17
CA2064678A1 (en) 1992-10-04
GR3020316T3 (en) 1996-09-30
ES2089395T3 (es) 1996-10-01
EP0507555A1 (de) 1992-10-07
SG43075A1 (en) 1997-10-17
JP2535119B2 (ja) 1996-09-18
IE921055A1 (en) 1992-10-07
MX9201513A (es) 1993-04-01
HU9201113D0 (en) 1992-06-29
DK0507555T3 (da) 1996-07-01
NZ242190A (en) 1997-06-24
EP0507555B1 (de) 1996-06-12
NO921279D0 (no) 1992-04-02
NO921279L (no) 1992-10-05
IL101353A0 (en) 1992-11-15
DE69211406D1 (de) 1996-07-18
CZ97292A3 (en) 1993-09-15
IE74884B1 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
ATE139120T1 (de) Verwendung von rapamycin zur behandlung des diabetes
NO902840L (no) Middel for transdermal applikasjon som inneholder gestoden
MX9102226A (es) Pañal o articulo absorbente con accesorio tensionante.
DE69428357D1 (de) Vorrichtung zur behandlung des diabetes mellitus
DE59107331D1 (de) Flupirtin in Kombination mit Antiparkinsonika zur Bekämpfung von Muskelverspannungen
DE3876081D1 (de) Sicherheitsgurt mit spannvorrichtung.
DE68910799D1 (de) Faserbehandlungszusammensetzung.
FI925466L (fi) Skivbroms foer driftblockhjul i en hiss
DE69325029D1 (de) Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus
DE68913162D1 (de) Kautschukmischungen.
DE3873468D1 (de) Sicherheitsgurthaltevorrichtung mit manueller lageverstellung.
DE68913088D1 (de) Faserbehandlungszusammensetzung.
DE69100250D1 (de) Spannzangenentkorker mit aussparung fuer den daumen.
IE891122L (en) Improvements in or relating to propanamine derivatives
DE59201740D1 (de) Polarisationsinterferometer mit Schmalbandfilter.
DE3862486D1 (de) Fungizide mischungen mit prochloraz.
DK44184A (da) Deodorant med silaniserede adsorbenter
NO891649D0 (no) Anordning med tannstangsheis.
FI920281L (fi) Drivhjul med utbytbar hjultandkrans foer motorfordon foersett med gummikedja.
NO885008D0 (no) Edelbeskytter for respirator.
ATE84417T1 (de) Prostaglandinanaloge zur verwendung in der medizin.
NO891035D0 (no) Vekstregulerende substanser.
KR920019218U (ko) 산소통을 교체할 수 있는 수경

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee